|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Piromelatine>> Market Analysis Reports |
Market Analysis Reports of Piromelatine |
|
2020 Insomnia (Sleep Deprivation) Drug Pipeline Report- Current Status, Phase, Mechanism, Route of Administration, and Companies, of Pre-Clinical And Clinical Drugs ... ), CYP1A2 Inducer for Insomnia, P005, piromelatine (Neu-P11), NFX91, CY18, CY20 ... P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2018 P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2018 SUMMARY P2X Purinoceptor 3 (P2RX3) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies. The latest report P2X Purinoceptor 3 (P2RX3) - ... 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H1 2018 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H1 2018 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 2B - Pipeline Review, H1 2018'; 5-Hydroxytryptamine Receptor 2B (5 HT2B ... 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H2 2017 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - Pipeline Review, H2 2017 SUMMARY According to the recently published report '5-Hydroxytryptamine Receptor 2B - Pipeline Review, H2 2017'; 5-Hydroxytryptamine Receptor 2B (5 HT2B ... 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin ... Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H1 2018 Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid Receptor 1 or TRPV1) - Pipeline Review, H1 2018 SUMMARY Transient Receptor Potential Cation Channel Subfamily V Member 1 (Capsaicin Receptor or Vanilloid ... P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H2 2019 P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H2 2019 SUMMARY According to the recently published report 'P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H2 2019'; P2X Purinoceptor 3 (P2RX3) pipeline Target constitutes close to 14 molecules. Out of which ... 5-Hydroxytryptamine Receptor 2B - Pipeline Review, H1 2020 5-Hydroxytryptamine Receptor 2B - Pipeline Review, H1 2020 SUMMARY 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) pipeline Target constitutes close to 9 molecules. Out of which approximately 8 molecules are developed by ... 5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 5-Hydroxytryptamine Receptor 2B - Drugs In Development, 2021 SUMMARY 5-Hydroxytryptamine Receptor 2B (5 HT2B or Serotonin Receptor 2B or HTR2B) - 5-Hydroxytryptamine receptor 2B (5-HT2B) or serotonin receptor 2B is a protein encoded by the HTR2B gene. It ... P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 P2X Purinoceptor 3 (P2RX3) - Drugs in Development, 2021 SUMMARY P2X Purinoceptor 3 (P2RX3) - P2X purinoceptor 3 is a protein encoded by the P2RX3 gene. It belongs to the family of purinoceptors. This receptor functions as a ligand-gated ion channel and ... Ocular Hypertension: Drug Development Pipeline Study, H1 2018 Ocular Hypertension pipeline comprises of 27 drugs under development as of March 2018. Of these, 2 drugs are in Phase 1 and 13 drugs in phase 2 and 6 drugs in Phase 3. Further, 5 drugs remain in Pre-clinical stage. One drug is in pre-registration stage. 20 ... |